Please try another search
For the three months ended 31 March 2022, Rennova Health Inc revenues increased from -$651K to $1.1M. Net loss applicable to common stockholders excluding extraordinary items increased from $54M to $138.2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Basic Earnings per Share excluding Extraordinary Items increased from -$2171.27 to -$28.71.
Period Ending: | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
---|---|---|---|---|
Total Revenue | 3.54 | 6.39 | 4.92 | 5.46 |
Gross Profit | 1.73 | 4.56 | 3.06 | 3.46 |
Operating Income | -0.601 | 2.1 | 0.752 | 1.4 |
Net Income | -0.548 | 1.28 | 0.806 | 0.82 |
Period Ending: | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
---|---|---|---|---|
Total Assets | 19.85 | 21.56 | 20.57 | 20.57 |
Total Liabilities | 47.41 | 48.57 | 48.86 | 49.67 |
Total Equity | -27.57 | -27.01 | -28.29 | -29.09 |
Period Ending: | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | -0.244 | 1.14 | 0.948 | |
Cash From Investing Activities | -0.178 | -0.534 | -0.364 | |
Cash From Financing Activities | -0.179 | -0.855 | -0.096 | |
Net Change in Cash | -0.602 | -0.248 | 0.489 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review